Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections
Public ClinicalTrials.gov record NCT01400867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Ceftaroline Versus Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study of safety, effectiveness, blood levels and tolerance of Ceftaroline fosamil in children with skin infections receiving antibiotic therapy in the hospital.
Study identification
- NCT ID
- NCT01400867
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Interventions
- Ceftaroline fosamil Drug
- Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam Drug
- Cephalexin or Clindamycin or Linezolid Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Months to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2011 (Type not available)
- Primary completion
- May 2014 (Actual)
- Completion
- Jul 2014 (Actual)
- Last update posted
- Jan 13, 2015
2011 – 2014
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site - Phoenix | Phoenix | Arizona | — | — |
| Investigational Site - Orange | Orange | California | — | — |
| Investigational Site - San Diego | San Diego | California | — | — |
| Investigational Site - Jacksonville | Jacksonville | Florida | — | — |
| Investigational Site - Atlanta | Atlanta | Georgia | — | — |
| Investigational Site - Chicago 1 | Chicago | Illinois | — | — |
| Investigational Site - Chicago 2 | Chicago | Illinois | — | — |
| Investigational Site - Springfield | Springfield | Illinois | — | — |
| Investigational Site - Shreveport | Shreveport | Louisiana | — | — |
| Investigational Site - Baltimore | Baltimore | Maryland | — | — |
| Investigational Site - Detroit | Detroit | Michigan | — | — |
| Investigational Site - Brooklyn | Brooklyn | New York | — | — |
| Investigational Site - New Hyde Park | New Hyde Park | New York | — | — |
| Investigational Site - Rochester | Rochester | New York | — | — |
| Investigational Site - Bronx | The Bronx | New York | — | — |
| Investigational Site - Akron | Akron | Ohio | — | — |
| Investigational Site - Cleveland 1 | Cleveland | Ohio | — | — |
| Investigational Site - Cleveland 2 | Cleveland | Ohio | — | — |
| Investigational Site - Toledo | Toledo | Ohio | — | — |
| Investigational Site - Pittsburgh | Pittsburgh | Pennsylvania | — | — |
| Investigational Site - Charleston | Charleston | South Carolina | — | — |
| Investigational Site - Memphis | Memphis | Tennessee | — | — |
| Investigational Site - Austin 1 | Austin | Texas | — | — |
| Investigational Site - Fort Worth | Fort Worth | Texas | — | — |
| Investigational Site - Norfolk | Norfolk | Virginia | — | — |
| Investigational Site - Richmond | Richmond | Virginia | — | — |
| Investigational Site - Seattle | Seattle | Washington | — | — |
| Investigational Site - Morgantown | Morgantown | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01400867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2015 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01400867 live on ClinicalTrials.gov.